Calian Group Ltd. (TSE:CGY – Get Free Report) was down 17.5% on Wednesday . The stock traded as low as C$38.91 and last traded at C$40.12. Approximately 113,648 shares were traded during trading, an increase of 255% from the average daily volume of 32,004 shares. The stock had previously closed at C$48.65.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on CGY shares. Royal Bank of Canada cut their target price on Calian Group from C$65.00 to C$60.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 22nd. CIBC lowered their target price on Calian Group from C$63.00 to C$62.00 in a report on Friday, February 14th.
Check Out Our Latest Analysis on Calian Group
Calian Group Price Performance
Calian Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, June 10th will be given a dividend of $0.28 per share. The ex-dividend date of this dividend is Tuesday, May 27th. This represents a $1.12 annualized dividend and a yield of 2.73%. Calian Group’s dividend payout ratio (DPR) is presently 119.93%.
Insider Buying and Selling
In other news, Director Lori O’neill acquired 600 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were bought at an average cost of C$44.75 per share, for a total transaction of C$26,850.00. Following the acquisition, the director now directly owns 600 shares in the company, valued at C$26,850. This trade represents a ? increase in their position. 0.63% of the stock is currently owned by company insiders.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Further Reading
- Five stocks we like better than Calian Group
- Stock Analyst Ratings and Canadian Analyst Ratings
- Symbotic Gets Big Earnings Lift: Is the Stock Investable Again?
- Best Stocks Under $10.00
- 3 Small-Cap Stocks With Room to Run Despite Tariff Headwinds
- Insider Trades May Not Tell You What You Think
- CRSPR Stock Could Be Ready to Deliver on Its Massive Promise
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.